公司資料
Graphite Bio 股價、新聞與催化劑
- 股票代碼:
- GRPH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for GRPH.
公司概覽
業務概覽
Graphite Bio was a gene-editing company focused on precision genome correction before its public-market wind-down. Its story was built around advanced editing science and rare-disease targets.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Graphite sat in gene-editing biotechnology.
商業模式特徵
The business depended on clinical and translational validation, as well as the feasibility of its editing approach.
生技產業定位
Graphite Bio is now best treated as a historical gene-editing case rather than a live catalyst name.
未來催化劑
- Graphite Bio is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than fresh pipeline news. The market no longer treats it like a live standalone development story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。